Estimating economic cost of HIV/AIDS-related diseases

Irina Farquhar, Alan Sorkin, Kent Summers, Earl Weir

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The study considers annual health care utilization and costs associated with human immunodeficiency virus (HIV) infection and the autoimmune disease syndrome (AIDS) complex by applying the previously developed disease and disease combination-specific cost of illness methodology. This study documents changes in age-specific mortality rates indicating the decline in age groups "20-39". We estimate annual economic losses resulting from twenty-four HIV/AIDS-related diseases among the U.S. population to be $18.2 billion. This estimate includes direct medical cost of almost $9.2 billion, 80% of which is compensated by Medicaid. We demonstrate that an add-on therapy with additional mean cost of $7,100 per person per year would be justifiable if it could reduce the risk of progression to AIDS by 19%.

Original languageEnglish (US)
Title of host publicationResearch in Human Capital and Development
Pages143-173
Number of pages31
Volume14
StatePublished - 2001
Externally publishedYes

Publication series

NameResearch in Human Capital and Development
Volume14
ISSN (Print)01943960

ASJC Scopus subject areas

  • Industrial relations
  • Political Science and International Relations

Fingerprint Dive into the research topics of 'Estimating economic cost of HIV/AIDS-related diseases'. Together they form a unique fingerprint.

Cite this